Fixed dose options often require larger adjustments than clinically preferred
Free shipping
FDA approves first generic of once-daily GLP-1 injection to lower blood sugar in patients with Type 2 diabetes, FDA (2024) FDA drug shortages, FDA (2024) Hikma receives FDA approval and launches the generic version of Victoza, Liraglutide, in the U.S., Hikma (2024) How Victoza works, Novo Nordisk Liraglutide injection, MedLinePlus (2021) Special report: Potential strategies for addressing GLP-1 and dual GLP-1/GIP receptor agonist shortages, Clinical Diabetes (2023) Type 2 diabetes, CDC (2024) Medically accurate: SingleCares Medical Review Board analyzes all of our content to confirm its in line with current medical advice
GLP-1 medications are a safe and effective tool in weight management, but should be used under the supervision of your doctor.
In theory, patients could pay enough outside Part D to exceed the Part D out-of-pocket limit
WEIGHT For those with deficiencies, B12 shots provide the potentially useful perk of increasing metabolism